APA

Eisenstein E. L., Nelson C. L., Simon T. A., Smitten A. L., Lapuerta P. & Mark D. B. (20020718). Vasopeptidase inhibitor reduces inhospital costs for patients with congestive heart failure: results from the IMPRESS trial. Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure. : American heart journal.

Chicago

Eisenstein Eric L, Nelson Charlotte L, Simon Teresa A, Smitten Allison L, Lapuerta Pablo and Mark Daniel B. 20020718. Vasopeptidase inhibitor reduces inhospital costs for patients with congestive heart failure: results from the IMPRESS trial. Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure. : American heart journal.

Harvard

Eisenstein E. L., Nelson C. L., Simon T. A., Smitten A. L., Lapuerta P. and Mark D. B. (20020718). Vasopeptidase inhibitor reduces inhospital costs for patients with congestive heart failure: results from the IMPRESS trial. Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure. : American heart journal.

MLA

Eisenstein Eric L, Nelson Charlotte L, Simon Teresa A, Smitten Allison L, Lapuerta Pablo and Mark Daniel B. Vasopeptidase inhibitor reduces inhospital costs for patients with congestive heart failure: results from the IMPRESS trial. Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure. : American heart journal. 20020718.